Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.

Frontiers in cellular and infection microbiology

Volumn 2, Issue , 2012, Pages 16-

  Bagnoli, Fabio ^a   Bertholet, Sylvie ^b   Grandi, Guido ^b  

^a Novartis Vaccines and Diagnostics Siena   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS VACCINE;

CLINICAL TRIAL (TOPIC); HUMAN; IMMUNOLOGY; METHODOLOGY; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE; VACCINATION;

CLINICAL TRIALS AS TOPIC; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; VACCINATION;

MLCS; MLOWN;

EID: 84870863751     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2012.00016     Document Type: Review

References (0)